Aurora Innovation, Inc. Form 8-K Summary
Business context and reporting period
This Form 8-K, dated January 30, 2023, reports a management appointment and related executive compensation arrangements. It does not provide quarterly or annual financial results; therefore, no reporting-period revenue, profit, cash flow, margin, debt, or liquidity data are presented.
Key financial and operating information
- Ossa F. Fisher was appointed President, effective upon her expected start date of February 13, 2023.
- Ms. Fisher will receive an annual base salary of $500,000 and an annual target bonus equal to 40% of base salary.
- She will receive a one-time award of 2,000,000 restricted stock units and 2,000,000 stock options. Each award will vest over four years, subject to a one-year cliff.
- The filing does not provide the exercise price, grant-date fair value, or detailed vesting terms for the stock options and restricted stock units.
Material changes versus the prior comparable period
- Chris Urmson will step down as President when Ms. Fisher begins employment but will remain Chief Executive Officer and a Section 16 officer.
- The filing states that Mr. Urmson’s departure as President was not due to any dispute or disagreement with the company, management, or Board.
- Ms. Fisher will be designated as an officer under Section 16 and will enter into the company’s standard indemnification agreement.
Guidance, outlook, risks, and unusual items
- Management stated that Ms. Fisher’s experience in growth strategy and scaling operations will support Aurora’s progress toward commercial launch.
- The appointment creates incremental cash compensation obligations and potential equity dilution through the new restricted stock unit and stock option awards.
- The filing identifies no financial guidance, liquidity update, debt modification, contingency, or material litigation matter.
- No related-party transaction, family relationship, or arrangement with another person concerning Ms. Fisher’s selection was reported.
Investor verification items
- Review Exhibit 10.1 for the complete employment agreement, including termination provisions, change-in-control terms, option exercise price, and detailed vesting conditions.
- Assess the accounting expense and potential dilution associated with the 4,000,000 equity awards.
- Monitor the transition of President responsibilities and the company’s progress toward commercial launch.
- Confirm subsequent filings for Ms. Fisher’s actual start date, Section 16 disclosures, and equity grant reporting.